gms | German Medical Science

43. Jahrestagung der Deutschen Gesellschaft der Plastischen, Rekonstruktiven und Ästhetischen Chirurgen e. V. (DGPRÄC), 17. Jahrestagung der Vereinigung der Deutschen Ästhetisch-Plastischen Chirurgen e. V. (VDÄPC)

13.09. - 15.09.2012, Bremen

Preclinical Models for Reconstructive Transplantation

Meeting Abstract

Search Medline for

  • presenting/speaker T. Herrler - Klinikum Großhadern, LMU München, Handchirurgie, Plastische & Ästhetische Chirurgie, München, Germany
  • T. Engelhardt - Klinikum Großhadern, LMU München, Handchirurgie, Plastische & Ästhetische Chirurgie, München, Germany
  • R. Giunta - Klinikum Großhadern, LMU München, Handchirurgie, Plastische & Ästhetische Chirurgie, München, Germany

Deutsche Gesellschaft der Plastischen, Rekonstruktiven und Ästhetischen Chirurgen. Vereinigung der Deutschen Ästhetisch-Plastischen Chirurgen. 43. Jahrestagung der Deutschen Gesellschaft der Plastischen, Rekonstruktiven und Ästhetischen Chirurgen (DGPRÄC), 17. Jahrestagung der Vereinigung der Deutschen Ästhetisch-Plastischen Chirurgen (VDÄPC). Bremen, 13.-15.09.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocDFRIIP04

DOI: 10.3205/12dgpraec247, URN: urn:nbn:de:0183-12dgpraec2473

Published: September 10, 2012

© 2012 Herrler et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Reconstructive transplantation represents an emerging field at the intersection of plastic and transplant surgery. Due to the adverse effects of immunosuppressive regimens and ethical issues reconstructive transplantation remains a therapeutic option in selected cases of complex defects. Alternative approaches such as tissue engineering are currently limited and are subject to on-going development. Meanwhile, improving outcomes, reducing immunosuppressants, and inducing tolerance are the major objectives in this novel field. Largely based on the experience of solid organ transplantation, the composition of various tissue types in reconstructive transplantation exhibits different immunological properties thus posing new challenges. Animal models are essential tools for enhanced understanding of the pathophysiology of ischemia-reperfusion injury and allorejection and may facilitate the development of novel treatment strategies. This presentation provides an overview of feasible preclinical models for reconstructive transplantation and their relevance to clinical practice.